Xiao J - Search Results

1

Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia.

Hua F, Hu Y, He GC, Lai SH, He Y, Zhang S, Deng Y, Han Y, Liu XD, Yang K, Zhong HX, Xiao J, Zheng ZZ, Yi H. Hua F, et al. Among authors: xiao j. Hematology. 2024 Dec;29(1):2377860. doi: 10.1080/16078454.2024.2377860. Epub 2024 Jul 15. Hematology. 2024. PMID: 39007733 Free article.

2

[Introplasmic IFN-γ level in circulating T cells detected by flow cytomertry and its relation with treatment efficiency in the patients with aplastic anemia].

Xiao J, Jiao YW, Zhong HX, Peng W, Zheng G, Ying MG. Xiao J, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1220-3. doi: 10.7534/j.issn.1009-2137.2013.05.027. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24156438 Chinese.

3

The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.

Yang K, Wu Y, Ma Y, Xiao J, Zhou Y, Yin X. Yang K, et al. Among authors: xiao j. Blood Cells Mol Dis. 2020 Sep;84:102442. doi: 10.1016/j.bcmd.2020.102442. Epub 2020 Apr 26. Blood Cells Mol Dis. 2020. PMID: 32387854

4

The Clinical Significance of the Spectrum of Interactions of the Rare IVS-II-5 G>C (HBB: c.315+5 G>C) Variation with Other β-Thalassemia Mutations in Southern China.

Liao G, Zhou Y, Yin X, He S, Wu Y, Xiao J, Geng Z, Huang Q, Luo G, Yang K. Liao G, et al. Among authors: xiao j. Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022034. doi: 10.4084/MJHID.2022.034. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35615327 Free PMC article.

5

A case of G6PD Utrecht associated with β-thalassemia responding to splenectomy.

Yang K, Liu X, Chen K, Luo S, Kong W, Huang W, Xiao J. Yang K, et al. Among authors: xiao j. Pediatr Blood Cancer. 2022 Sep;69(9):e29837. doi: 10.1002/pbc.29837. Epub 2022 Jun 13. Pediatr Blood Cancer. 2022. PMID: 35695473

6

Whole exome sequencing identifies a novel SPTB frameshift mutation causing hereditary spherocytosis in the Chinese population.

Liu XD, Yang K, Xiao J, Huang H, Zhang XD, Huang JY. Liu XD, et al. Among authors: xiao j. Ann Hematol. 2022 Oct;101(10):2355-2357. doi: 10.1007/s00277-022-04900-0. Epub 2022 Jun 21. Ann Hematol. 2022. PMID: 35726106 No abstract available.

7

[Predictors of Hematologic Responses in Patients with Non-Transfusion-Dependent β-Thalassemia Receiving Thalidomide Therapy].

Yang K, Yin XL, Liu XD, Hua F, Peng W, Li L, Chen K, Zhang J, Luo S, Xiao J. Yang K, et al. Among authors: xiao j. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Oct;30(5):1519-1526. doi: 10.19746/j.cnki.issn.1009-2137.2022.05.033. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 36208259 Chinese.

8

Thalidomide-associated autoimmune hemolytic anemia.

Wu Y, Yang K, Kong W, Xiao J, Liu X. Wu Y, et al. Among authors: xiao j. Pediatr Blood Cancer. 2023 Apr;70(4):e30093. doi: 10.1002/pbc.30093. Epub 2022 Nov 9. Pediatr Blood Cancer. 2023. PMID: 36349983 No abstract available.

9

Hematopoietic cell transplantation for congenital dyserythropoietic anemia IV caused by compound heterozygous KLF1 mutations.

Yang K, Nie W, Huang Q, Liao G, Xiao J, Yin X. Yang K, et al. Among authors: xiao j. Ann Hematol. 2023 Jun;102(6):1621-1624. doi: 10.1007/s00277-023-05175-9. Epub 2023 Mar 31. Ann Hematol. 2023. PMID: 37002443 No abstract available.

10

Chronic hemolytic anemia associated to G6PD Canton aggravated by a KLF1 mutation.

Yang K, Wu Y, Xiao J. Yang K, et al. Among authors: xiao j. Pediatr Blood Cancer. 2023 Apr 24:e30388. doi: 10.1002/pbc.30388. Online ahead of print. Pediatr Blood Cancer. 2023. PMID: 37092890 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,349 results

Search Page

Filters